Literature DB >> 25407652

EZH2: a potential new target in T-cell lymphoma?

Lisa Giulino-Roth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25407652     DOI： 10.3109/10428194.2014.987770

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Structure of the PRC2 complex and application to drug discovery.

Authors:  Yi Shi; Xiao-Xi Wang; You-Wen Zhuang; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-04-17       Impact factor: 6.150

2.  Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.

Authors:  Daisuke Honma; Osamu Kanno; Jun Watanabe; Junzo Kinoshita; Makoto Hirasawa; Emi Nosaka; Machiko Shiroishi; Takeshi Takizawa; Isao Yasumatsu; Takao Horiuchi; Akira Nakao; Keisuke Suzuki; Tomonori Yamasaki; Katsuyoshi Nakajima; Miho Hayakawa; Takanori Yamazaki; Ajay Singh Yadav; Nobuaki Adachi
Journal:  Cancer Sci       Date:  2017-08-08       Impact factor: 6.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.